Breaking News

Binah.ai rolls out contactless BP monitoring using smartphone camera

Not rendering correctly? View this email as a web page here.

Supreme court weighs Biden's workplace vaccine requirements

By Julie Rovner, Kaiser Health News Friday, January 7, 2022 7:22 PM

Lower courts have split on whether the federal government has the authority to issue such rules and whether they can take effect while the cases are argued.

Read more »

Amylyx Pharma's IPO lands $190M as ALS drug begins FDA review

By Frank Vinluan Friday, January 7, 2022 6:23 PM

It's the first week of the new year, and the life sciences sector continued the IPO momentum of 2021 as Wall Street welcomed three new biotech companies. Here's a look at the IPOs of Amylyx Pharmaceuticals, CinCor, and Vigil Neuroscience, which raised a combined $482 million to support work on drugs addressing neurodegenerative and cardiovascular disorders.

Read more »

In 2022, California's ballot will be heavy on healthcare

By Samantha Young, Kaiser Health News Friday, January 7, 2022 12:54 PM

Voters will weigh whether to overturn a state law that bans flavored tobacco products and will likely consider increasing the cap on medical malpractice awards.

Read more »

2022 predictions: Simpler, trusted health intelligence sharing

By Tom Skelton Friday, January 7, 2022 12:43 PM

The CEO of Surescripts believes we are living in an unpredictable world coupled with an explosion of innovation that aims to solve challenges like the cost of medications, administrative inefficiency and gaps in patient information.

Read more »

Biotech dominates medtech in numbers

By Emma Bardin Friday, January 7, 2022 12:28 PM

In 2021 biotech had a median deal of $10 million and an average deal of $36.9 million, according to the report by PitchBook Data. Comparatively, medtech locked in an median of $3.9 million and $12.6 million average.

Read more »

Sanofi bets big on AI again, paying $100M to start drug R&D pact with Exscientia

By Frank Vinluan Friday, January 7, 2022 11:15 AM

Sanofi's new alliance with artificial intelligence biotech Exscientia spans up to 15 small molecule drugs in cancer and immunology. If drugs from the partnership reach the market, Exscientia could earn as much as $5.2 billion in milestone payments.

Read more »

Digital health investment opportunities in 2022

By Dr. Namrata Rastogi Friday, January 7, 2022 8:15 AM

Child and adolescent mental health, palliative care and clinical AI are among opportunities that investors should consider closely this year an in the future.

Read more »

   

No comments